Hillel Galitzer
Chief Operating OfficerDr. Hillel Galitzer, PhD, MBA, has been the Chief Operating Officer at Entera Bio Ltd. since February 2014. Dr. Galitzer has years of experience in medical research and molecular biology and was mentored by two world renowned researchers in the field of PTH and calcium regulation. Dr. Galitzer is the co-Founder and Chief Operating Officer of Optivasive Inc. He served as Director of Scientific Development at Entera Bio Ltd. since July 2010. From August 2010 to February 2014, Dr. Galitzer served as an Analyst and Chief Operating Officer of Hadasit Bio Holdings Ltd. He has written numerous publications in tier one peer reviewed articles and has lectured and presented in international conferences and universities. Dr. Galitzer received his Ph.D. from the Hebrew University Medical School in Jerusalem and his M.B.A. from Bar-Ilan University in Israel. He has done B.Med.Sc. from the Hebrew University Medical School in Jerusalem.
Positions
- Company NameEntera Bio Ltd.Stock CodeENTXPositionChief Operating OfficerColleagues
- MJMiranda J. ToledanoCEO & Director
- GJGeno J. GermanoIndependent Chairman
- GBGregory BurshteinChief of Research & Development
- DYDana Yaacov-GarbeliChief Financial Officer
- RBRachel B. WagmanChief Clinical Advisor
- FCFelicia CosmanChairman of Scientific Advisory Board & Chief Clinical Advisor (Endocrinology)
- HTHaya TaitelNon-Employee Independent Director
- SDSteven D. RubinIndependent Director
